|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.13 USD | +2.23% |
|
-6.35% | +148.80% |
| May. 07 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
| May. 06 | Rate Cut Hopes Lift Exchange-Traded Funds, Equity Futures Pre-Bell Monday | MT |
ADC Therapeutics SA reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was USD 18.99 million compared to USD 46.5 million a year ago. Net loss was USD 59.43 million compared to USD 16.66 million a year ago.
Basic loss per share from continuing operations was USD 0.74 compared to USD 0.22 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +148.80% | 397M | |
| +7.52% | 113B | |
| +11.38% | 106B | |
| -12.64% | 22.22B | |
| +0.44% | 22.27B | |
| -4.18% | 19.43B | |
| -37.85% | 17.87B | |
| -8.58% | 17.24B | |
| +37.41% | 12.52B | |
| -23.95% | 8.34B |
ADC THERAPEUTICS SA 